1. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
2. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
3. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
4. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
5. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
6. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
7. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
8. What is the main duty of a Federal Inspector?
9. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
10. The Authority may open its accounts with:
11. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
12. What condition must be met for an application for renewal of a licence to be entertained?
13. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
14. In what circumstances shall a drug not be deemed misbranded or adulterated?
15. What type of containers are ophthalmic solutions and suspensions required to be contained in?
16. The Central Research Fund fee collected by the Authority will be utilized for:
17. Who is responsible for carrying out the audit of the Authority's accounts?
18. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
19. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
20. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
21. The Authority shall levy and collect fees for its functions at rates determined by:
22. Who is considered an "investigator" under the Drugs (Research) Rules?
23. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
24. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
25. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
26. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
27. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
28. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
29. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
30. What are "Medicated Cosmetics" under Schedule-I?
31. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
32. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
33. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
34. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
35. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
36. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
37. The Drugs Act, 1976 extends to which of the following areas?
38. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
39. Under what conditions is contract manufacture permissible?
40. For drugs other than those falling under specific categories, whose approval is required for the specifications?
41. What is the duration of a license to import drugs, unless suspended or canceled?
42. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
43. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
44. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
45. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
46. Under what conditions are drug advertisements to the general public generally permitted?
47. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
48. What is the short title of the rules that govern the Drugs Appellate Board?
49. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
50. What labeling requirements apply to drugs manufactured for experimental purposes?
51. What action should the Authority take in response to objections raised by the Auditor-General?
52. What does an Inspector require from a person during a search or seizure under Schedule-V?
53. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
54. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
55. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
56. Which power of the Inspector requires specific authorization by the Government?
57. When does an Inspector need to divide a sample into three portoons instead of four?
58. What is the Appellate Board's authority to call for the record of a case for review?
59. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
60. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
61. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
62. What does the term "batch number (or lot number)" refer to?
63. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
64. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
65. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
66. What is the purpose of an "airlock" in pharmaceutical manufacturing?
67. Within what time frame should the Authority submit its annual report to the Federal Government?
68. What is the commencement date for the Drugs (Specifications) Rules, 1978?
69. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
70. What is the purpose of the criteria regarding medical representatives?
71. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
72. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
73. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
74. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
75. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
76. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
77. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
78. What is the purpose of the Committee on Drugs Evaluation?
79. Which type of research involves intervention, treatment, or medication programs using human subjects?
80. Who is responsible for maintaining records of quarterly production and disposal of a drug?
81. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
82. What is the primary function of the Federal Drug Laboratory as stated in the rules?
83. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
84. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
85. Which power of the Inspector requires specific authorization by the Government?
86. Who serves as the ex-officio Chairman of the Appellate Board?
87. How many members does the Policy Board consist of?
88. Which of the following statements about advertisement material is NOT true?
89. What are "Medicated Cosmetics" under Schedule-I?
90. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
91. Which of the following offenses punishable under Schedule-III is non-cognizable?
92. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
93. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
94. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
95. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
96. What is the purpose of the license to manufacture drugs for experimental purposes?
97. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
98. What is the role of the Quality Control Department in the manufacturing process?
99. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
100. What is the purpose of the Drugs (Research) Rules, 1978?
